Literature DB >> 6673972

Mass spectral investigation of the metabolites of lorcainide in man.

W F Lauwers, W E Meuldermans, J O Bracke.   

Abstract

[3H] Lorcainide hydrochloride was administered orally to healthy male volunteers. About 97% of the total radioactivity was excreted in the urine and faeces within four days of its administration. The metabolites were purified by adsorption chromatography, liquid-liquid extraction, thin layer chromatography or by gas chromatography-mass spectrometry after silylation of the samples. When there was a sufficient amount available, the samples were submitted to a nuclear magnetic resonance analysis. The results were confirmed by comparison of spectral data obtained from the reference compounds. The major metabolites of lorcainide were formed by aromatic hydroxylation, O-methylation and oxidative N-dealkylation. The urinary phenolic metabolites were present both as free aglycons and conjugates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6673972     DOI: 10.1007/BF03188767

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  Isolation and identification of two hydroxylated metabolites of phenazopyridine in rat urine.

Authors:  D Pitrè; R Maffei-Facino
Journal:  Farmaco Sci       Date:  1977-06

2.  Metabolism of DL-[14C]prenylamine in man.

Authors:  G Remberg; M Eichelbaum; G Spiteller; H J Dengler
Journal:  Biomed Mass Spectrom       Date:  1977-10

3.  Identification of hydroxyhalobiphenyls as their methyl ethers by gas chromatography mass spectrometry.

Authors:  M T Tulp; K Olie; O Hutzinger
Journal:  Biomed Mass Spectrom       Date:  1977-10

4.  Use of ethyl ethers, deuteriomethyl ethers and cyclic n-butylboronates of hydroxychlorobiphenyls in identification of metabolites of polychlorinated biphenyls.

Authors:  M T Tulp; O Hutzinger
Journal:  J Chromatogr       Date:  1977-09-11

5.  Excretion and metabolism of lorcainide in rats, dogs and man.

Authors:  W Meuldermans; R Hurkmans; E Swysen; J Hendrickx; J Thijssen; W Lauwers; J Heykants
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

6.  Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.

Authors:  E Carmeliet; P A Janssen; R Marsboom; J M Van Nueten; R Xhonneux
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-01
  6 in total
  1 in total

1.  Excretion and metabolism of lorcainide in rats, dogs and man.

Authors:  W Meuldermans; R Hurkmans; E Swysen; J Hendrickx; J Thijssen; W Lauwers; J Heykants
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.